Chemical Compound

paroxetine

CAS Registry Number 61869-08-7

Back to search Request a Quote

Primary Record

paroxetine

In stock: 7,097 g
Purity: 98.5 %
CAS: 61869-08-7

Compound Identifiers & Properties

CAS: 61869-08-7
PubChem CID: 43815
SMILES: C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
Canonical SMILES: Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1

Names & Synonyms

paroxetine
Paxil
Frosinor
Motivan
Casbol
PaxPar
Paroxetina
Paxetil
Aropax
Paroxetinum
Seroxat
Paxil CR
Besitram
61869-08-7
Arketis
Daparox
Parogen
Xetanor
Arotin
(-)-Paroxetine
Paroxetine Hcl
Oxetine
Pexeva
Paroxetine Base
Flumetsulam
Brisdelle
Paroxetine hydrochloride
Seroxat CR
Paroxetinum [INN-Latin]
[3H]Paroxetine
Paroxetine (TN)
3h-paroxetine
Paroxetina [INN-Spanish]
Paroxetine.HCl
Paroxetin HCL
Paxil, Pexeva
Paroxetine Acetate
Paroxetine Mesilate
Paroxetine Mesylate
(-)3s,4r-paroxetine
(+/-)-Paroxetine
Seroxat (TN)
Aropax 20
PAXILCR
Paxil (TN)
Paroxetine (USP/INN)
Paroxetine [USAN:INN:BAN]
Paroxetine HCl hydrate
Paroxetine, (+/-)-
RefChem:6104
BRL 29060
BRL-29060
C19H20FNO3
Spectrum_001752
CHEMBL490
PAROXETINE [MI]
SpecPlus_000788
AC1L2AKL
FG-7051
PAROXETINE [INN]
Paxil (as hydrochloride)
Prestwick3_000851
Spectrum5_001665
CHEBI:7936
PAROXETINE [USAN]
DTXSID3023425
FG 7051
PAROXETINE [VANDF]
Paroxetine, trans-(+/-)-
D06GDY
D06VML
UNII-41VRH5220H
AC1Q4LV6
PAROXETINE [MART.]
32Q7TW8BX7
DTXCID703425
41VRH5220H
CHEMBL1708
PAROXETINE [WHO-DD]
UNII-32Q7TW8BX7
UNII-X2ELS050D8
Epitope ID:2278423
SCHEMBL27799
BSPBio_000861
KBioSS_002232
BIDD:GT0673
DivK1c_006884
Paroxetine [USAN:BAN:INN]
AHOUBRCZNHFOSL-YOEHRIQHSA-N
MFCD00869588
AC1Q1H18
BPBio1_000949
GTPL4790
orb1909599
Paroxetine hydrochloride hydrate
Paroxetine hydrochloride hemihydrate
PAROXETINE, HYDROCHLORIDE
SCHEMBL29358021
BDBM22416
HSDB 7175
KBio1_001828
KBio2_002232
KBio2_004800
KBio2_007368
PAROXETINE HCL HEMIHYDRATE
N06AB05
Paroxetine Hydrochloride Anhydrous
BRL 29060A
BRL-29060A
HMS2090H05
ZINC527386
BRL29060
CID43815
KS-00000JK2
C19-H20-F-N-O3
NNC-20-7051
Tox21_113123
BDBM50331515
EBC-26608
FG7051
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
AKOS015888636
Tox21_113123_1
(3s,4r)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
AC-8185
AN-8247
DB00715
SDCCGSBI-0051908.P003
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
NCGC00025355-02
NCGC00025355-03
NCGC00025355-04
NCGC00025355-05
NCGC00025355-06
NCGC00025355-07
NCGC00025355-08
NCGC00025355-09
NCGC00025355-12
NCGC00025355-13
NCGC00025355-22
NCGC00025355-23
NCGC00182968-01
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
AJ-23329
SC-16100
SC-22977
SY289602
SBI-0051908.P002
CAS-61869-08-7
HY-122272
J259.859K
LS-114249
TL8003967
1596B
AB00514724
CS-0083299
FT-0602526
NS00000037
Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S,4R)-
C07415
C10075
D02362
EN300-150199
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine
AB00053704-21
AB00053704_22
AB00053704_23
Paroxetine Hydrochloride Anhydrous EP Impurity E
869P087
A833457
F615527
paroxetine hydrochloride (anhydrous or hemihydrate)
Q408471
(3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
I14-7752
Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-,(3S,4R)-
BRD-K37991163-003-02-7
BRD-K37991163-003-13-4
BRD-K37991163-003-14-2
BRD-K37991163-050-05-1
BRD-K37991163-050-18-4
Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S-trans)-
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine
110429-35-1
130855-15-1
(-)-TRANS-4-(P-FLUOROPHENYL)-3-((3,4-(METHYLENEDIOXY)PHENOXY)METHYL)PIPERIDINE
(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine
(3S,4R)-3-((1,3-BENZODIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)PIPERIDINE
(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine
3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride
Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3R,4S)-rel-
Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, trans-
Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, trans-(+/-)-
Rel-(3R,4S)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S,4R)-3-(1,3-Benzodioxole-5-yloxy)methyl-4-(4-fluorophenyl)piperidine
(3S,4R)-3-(1,3-dioxaindan-5-yloxy)methyl-4-(4-fluorophenyl)piperidine
(3S,4R)-3-[(1,3-dioxaindan-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
3beta-[(1,3-Benzodioxol-5-yl)oxymethyl]-4alpha-(4-fluorophenyl)piperidine
5-[[(3S,4R)-4-(4-Fluorophenyl)-3-piperidyl]methoxy]-1,3-benzodioxole
(-)-3beta-[(1,3-Benzodioxol-5-yl)oxymethyl]-4alpha-(4-fluorophenyl)piperidine
(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]piperidine
(3S)-3beta-(1,3-Benzodioxole-5-yloxymethyl)-4alpha-(4-fluorophenyl)piperidine
(3S,4R)-3-((2H-1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S,4R)-3-[(Benzo[d][1,3]dioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
(3S,4R)-3-{[(2H-1,3-Benzodioxol-5-yl)oxy]methyl}-4-(4-fluorophenyl)piperidine
(3S,4R)-3beta-[[(1,3-Benzodioxol-5-yl)oxy]methyl]-4alpha-(4-fluorophenyl)piperidine
(3S-TRANS)-3-[(1,3-BENZODIOXOL-5-YLOXY)METHYL]-4-(4-FLUOROPHENYL)PIPERIDINE
piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S,4R)-
Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S-trans)-
Piperidine,3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S,4R)-
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine hydrochloride hemihydrate
78246-49-8
8PR
cis-Paroxetine; Paroxetine USP Related Compound D;[(3S,4R)-4-(p-Fluorophenyl)-3-piperidyl](1,3-dioxa-5-indanyloxy)methane